Breast Neoplasms: all 12,820 studies

Page 49 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast CancerTerminatedNCT00176488Phase 2Results posted
• A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast CancerCompletedNCT00171704Phase 3Results posted
• Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.CompletedNCT00171340Phase 3Results posted
• The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast CancerCompletedNCT00171314Phase 3Results posted
• Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell FunctionTerminatedNCT00169104Phase 2/3Results posted
• Study for Using Radiosurgery on Limited Metastases of Breast CancerCompletedNCT00167414Not applicableResults posted
• Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment RegimensCompletedNCT00149214Phase 2Results posted
• Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast CancerCompletedNCT00148668Phase 2Results posted
• Study Evaluating HKI-272 in TumorsCompletedNCT00146172Phase 1Results posted
• Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast CancerCompletedNCT00143390Phase 3Results posted
• A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast CancerTerminatedNCT00140140Phase 1/2Results posted
• Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast CancerTerminatedNCT00138125Phase 2Results posted
• Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast CancerTerminatedNCT00132002Phase 2Results posted
• Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer PatientsCompletedNCT00130533Phase 3Results posted
• EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast CancerCompletedNCT00129935Phase 3Results posted
• FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer PatientsCompletedNCT00129389Phase 3Results posted
• Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00129376Phase 2Results posted
• XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast CancerCompletedNCT00127933Phase 4Results posted
• S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.CompletedNCT00127205Phase 3Results posted
• Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant TreatmentCompletedNCT00121992Phase 3Results posted
• A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast CancerCompletedNCT00121836Phase 4Results posted
• Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast CancerCompletedNCT00121134Not applicableResults posted
• Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerCompletedNCT00119262Phase 2Results posted
• Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous TamoxifenCompletedNCT00118157Phase 2Results posted
• Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast CancerTerminatedNCT00118053Phase 2Results posted
• St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast CancerTerminatedNCT00110136Phase 2Results posted
• ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast CancerCompletedNCT00110084Phase 2Results posted
• S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast CancerCompletedNCT00107276Phase 2Results posted
• Pemetrexed as the First Treatment in Advanced or Metastatic Breast CancerCompletedNCT00106002Phase 2Results posted
• BAY43-9006 - Phase II in Advanced Breast CancerCompletedNCT00101400Phase 2Results posted
• Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.Active, not recruitingNCT00099437Phase 3Results posted
• A Study of E7389 in Advanced/Metastatic Breast Cancer PatientsCompletedNCT00097721Phase 2Results posted
• Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast CancerCompletedNCT00096356Phase 1Results posted
• Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast CancerTerminatedNCT00096109Phase 2Results posted
• Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00093808Phase 2Results posted
• Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast CancerCompletedNCT00093795Phase 3Results posted
• Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast CancerCompletedNCT00093145Phase 2Results posted
• Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast CancerCompletedNCT00091832Phase 2Results posted
• A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast CancerCompletedNCT00091442Phase 3Results posted
• Letrozole in Preventing Breast Cancer in Postmenopausal WomenCompletedNCT00090857Phase 2Results posted
• Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast CancerTerminatedNCT00090844Phase 2Results posted
• Lapatinib In Chemotherapy-Naive Or Metastatic Breast CancerCompletedNCT00089999Phase 2Results posted
• Study Of Ispinesib In Subjects With Breast CancerCompletedNCT00089973Phase 2Results posted
• AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast CancerCompletedNCT00089661Phase 3Results posted
• A Study of Xeloda (Capecitabine) in Women With High-Risk Breast CancerCompletedNCT00089479Phase 3Results posted
• Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast CancerTerminatedNCT00088985Phase 2Results posted
• S0300, Celecoxib in Preventing Breast Cancer in Premenopausal WomenTerminatedNCT00088972Phase 2Results posted
• Genetic Testing in Predicting Response to Paclitaxel in Women With Breast CancerTerminatedNCT00088829Phase 2Results posted
• Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast CancerCompletedNCT00087178Phase 3Results posted
• S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast CancerCompletedNCT00087152Phase 2Results posted
• Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00086957Phase 1/2Results posted
• Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast CancerCompletedNCT00083174Phase 3Results posted
• Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast CancerCompletedNCT00082810Phase 2Results posted
• Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast CancerCompletedNCT00082641Phase 1/2Results posted
• Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT00082433Phase 3Results posted
• Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT00080301Phase 3Results posted
• Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast CancerTerminatedNCT00079326Phase 2Results posted
• A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00077857Phase 2Results posted
• Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast CancerCompletedNCT00077376Phase 2Results posted
• AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast CancerCompletedNCT00076024Phase 1/2Results posted
• S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast CancerCompletedNCT00075764Phase 3Results posted
• Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast CancerCompletedNCT00075270Phase 3Results posted
• Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast CancerTerminatedNCT00074269Phase 2Results posted
• Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast CancerCompletedNCT00074152Phase 3Results posted
• Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast CancerCompletedNCT00073528Phase 3Results posted
• Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast CancerCompletedNCT00073073Phase 2Results posted
• Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In SituCompletedNCT00072462Phase 3Results posted
• Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node MicrometastasesCompletedNCT00072293Not applicableResults posted
• S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast CancerActive, not recruitingNCT00070564Phase 3Results posted
• S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast CancerCompletedNCT00068601Phase 3Results posted
• GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast CancerCompletedNCT00068588Phase 2Results posted
• Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast CancerCompletedNCT00068341Phase 2Results posted
• Premenopausal Endocrine Responsive Chemotherapy TrialTerminatedNCT00066807Phase 3Results posted
• Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast CancerCompletedNCT00066703Phase 3Results posted
• Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerCompletedNCT00066690Phase 3Results posted
• Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast CancerCompletedNCT00066573Phase 3Results posted
• Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast CancerTerminatedNCT00063934Phase 1/2Results posted
• Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane TherapyCompletedNCT00063570Phase 2Results posted
• Study Evaluating Temsirolimus (CCI-779) In Breast NeoplasmsCompletedNCT00062751Phase 2Results posted
• Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast CancerCompletedNCT00058058Not applicableResults posted
• Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast CancerCompletedNCT00057941Phase 2Results posted
• Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast CancerCompletedNCT00054275Phase 2Results posted
• Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast CancerCompletedNCT00054132Phase 2Results posted
• Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast CancerCompletedNCT00054028Phase 1/2Results posted
• Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast CancerCompletedNCT00050167Phase 1Results posted
• Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal TherapyCompletedNCT00050011Phase 3Results posted
• Vaccine and Chemotherapy for Previously Untreated Metastatic Breast CancerTerminatedNCT00048893Phase 1/2Results posted
• EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast CancerCompletedNCT00046891Phase 3Results posted
• Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast CancerCompletedNCT00045032Phase 3Results posted
• Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II TrialTerminatedNCT00041470Phase 1/2Results posted
• Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast CancerCompletedNCT00041119Phase 3Results posted
• S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast CancerCompletedNCT00041067Phase 2Results posted
• Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast CancerCompletedNCT00038467Phase 3Results posted
• Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On TamoxifenCompletedNCT00038103Phase 2Results posted
• Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneCompletedNCT00036270Phase 3Results posted
• Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu OverexpressionCompletedNCT00033514Phase 1/2Results posted
• Vaccine Therapy in Treating Patients at High Risk for Breast Cancer RecurrenceCompletedNCT00030823Not applicableResults posted
• Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast CancerCompletedNCT00024102Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast CancerCompletedNCT00022672Phase 3Results posted
• Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast CancerCompletedNCT00022516Phase 3Results posted

← Breast Neoplasms overview